ALTER — Theradiag SA Balance Sheet
0.000.00%
- €16.44m
- €12.36m
- €12.20m
- 78
- 38
- 18
- 38
Annual balance sheet for Theradiag SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 3.42 | 2.9 | 3.54 | 7.11 | 6.39 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.52 | 1.35 | 1.92 | 2.31 | 2.09 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7.05 | 6.35 | 9.25 | 11.4 | 10.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.308 | 0.3 | 0.25 | 0.18 | 0.204 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.92 | 8.76 | 12.2 | 14.8 | 14.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.2 | 2.06 | 6.07 | 2.95 | 3.44 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.5 | 2.23 | 6.07 | 5 | 4.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 6.43 | 6.54 | 6.16 | 9.79 | 9.6 |
| Total Liabilities & Shareholders' Equity | 8.92 | 8.76 | 12.2 | 14.8 | 14.4 |
| Total Common Shares Outstanding |